尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the complete record of transactions filed by Vitullo Nicole, 董事. Officer active across 2 companies, notably Esperion Therapeutics, Inc.. Aggregated, 3 disclosures have been published. History available since 27 May 2021. The latest transaction was filed on 15 June 2023 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Nicole Vitullo is a Director at Esperion Therapeutics, Inc. and Marinus Pharmaceuticals Inc. She plays a key role in overseeing the activities of these companies and guiding their strategy. Nicole leverages her expertise to contribute to strategic decision-making within the boards.